Peter D. Suzdak
2013
In 2013, Peter D. Suzdak earned a total compensation of $713.4K as Chief Executive Officer at Rexahn Pharmaceuticals.
Compensation breakdown
| Bonus | $82,500 |
|---|---|
| Option Awards | $320,465 |
| Salary | $298,270 |
| Other | $12,147 |
| Total | $713,382 |
Suzdak received $320.5K in option awards, accounting for 45% of the total pay in 2013.
Suzdak also received $82.5K in bonus, $298.3K in salary and $12.1K in other compensation.
Rankings
In 2013, Peter D. Suzdak's compensation ranked 8,048th out of 12,286 executives tracked by ExecPay. In other words, Suzdak earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,048 out of 12,286 | 35th |
Division Manufacturing | 2,911 out of 4,612 | 37th |
Major group Chemicals And Allied Products | 907 out of 1,462 | 38th |
Industry group Drugs | 687 out of 1,156 | 41st |
Industry Pharmaceutical Preparations | 546 out of 890 | 39th |
Source: SEC filing on April 18, 2016.
Suzdak's colleagues
We found three more compensation records of executives who worked with Peter D. Suzdak at Rexahn Pharmaceuticals in 2013.